12/05/2026
🧠 A major milestone for the sustainability of Luxembourg's Parkinson's programme 🇱🇺
On 12 May, NCER-PD celebrated an important milestone at the new Luxembourg Research Clinic, marking the signing of a consortium agreement after two successful phases funded by the Luxembourg National Research Fund - FNR
This step secures the long-term sustainability of the programme and further strengthens Luxembourg's role in advancing precision medicine for Parkinson's disease ✨
NCER-PD brings together strong national partners: Luxembourg Institute of Health (LIH), University of Luxembourg, Centre Hospitalier de Luxembourg (CHL), and Laboratoire National de Santé (LNS), in close collaboration with Hôpitaux Robert Schuman and Centre Hospitalier Emile Mayrisch.
Over the past years, the programme has contributed to major advances in Parkinson's research through large patient studies, biomarker discovery, and international collaborations 🤝 such as the Parkinson's Progression Markers Initiative (PPMI).
The event at the Luxembourg Research Clinic was also a moment to highlight the importance of working closely across research and clinical partners to turn science into real impact for patients 💡
Discover more about NCER-PD and key outcomes from the event here: https://www.lih.lu/en/article/landmark-agreement-ensures-sustainability-of-luxembourg-parkinsons-programme/